A summary of stock option activity is as follows for the three months ended March 28, 2026 (number of options in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | Number of options | | Weighted-average exercise price | | Weighted-average remaining contractual term | | Aggregate intrinsic value(1) | | Outstanding at December 31, 2025 | 4,664 | | | $ | 7.77 | | | 7.06 | | $ | 7,780 | | | Granted | 1,047 | | | 8.60 | | | | | | | Exercised | (30) | | | 4.00 | | | | | | | Forfeited or canceled | (14) | | | 12.01 | | | | | | | Outstanding at March 28, 2026 | 5,667 | | | $ | 7.93 | | | 7.42 | | $ | 11,840 | | | Exercisable and vested at March 28, 2026 | 2,953 | | | $ | 8.94 | | | 6.19 | | $ | 5,721 | |
(1)The aggregate intrinsic value is based upon the difference between the Company’s closing stock price at the date of the consolidated condensed balance sheets and the exercise price of the stock option for in-the-money stock options. The intrinsic value of outstanding stock options fluctuates based upon the trading value of the Company’s Class A common stock.
|